CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

BioNxt Advances GLP-1 Sublingual Semaglutide ODF Program with Next Stage of Delivery Development Underway

GLP-1 Sublingual Semaglutide ODFPositive
AI Analysis

Summary

BioNxt is advancing development of a GLP-1 sublingual semaglutide oral dispersible film (ODF) formulation with the next stage of delivery development underway.

Importance:2/10
Sentiment:
0.30
GLP-1drug deliverysemaglutidesublingualODF
Related Companies

Read the original article

Published by yahoo_finance on July 6, 2026 7:05 AM

Read Original